Jushi (OTCMKTS:JUSHF – Get Free Report) is one of 53 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its rivals? We will compare Jushi to similar businesses based on the strength of its earnings, institutional ownership, analyst recommendations, risk, profitability, dividends and valuation.
Profitability
This table compares Jushi and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Jushi | -24.16% | -320.66% | -10.31% |
Jushi Competitors | -48.57% | -31.53% | -7.91% |
Valuation & Earnings
This table compares Jushi and its rivals gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Jushi | $269.45 million | -$65.10 million | -2.13 |
Jushi Competitors | $326.19 million | -$162.92 million | -10.08 |
Volatility and Risk
Jushi has a beta of -0.16, suggesting that its stock price is 116% less volatile than the S&P 500. Comparatively, Jushi’s rivals have a beta of 1.32, suggesting that their average stock price is 32% more volatile than the S&P 500.
Institutional & Insider Ownership
21.7% of Jushi shares are held by institutional investors. Comparatively, 16.2% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.0% of Jushi shares are held by company insiders. Comparatively, 22.5% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Analyst Ratings
This is a summary of recent ratings and target prices for Jushi and its rivals, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Jushi | 0 | 2 | 0 | 0 | 2.00 |
Jushi Competitors | 246 | 546 | 909 | 66 | 2.45 |
As a group, “Medicinals & botanicals” companies have a potential upside of 75.86%. Given Jushi’s rivals stronger consensus rating and higher possible upside, analysts clearly believe Jushi has less favorable growth aspects than its rivals.
Summary
Jushi rivals beat Jushi on 9 of the 13 factors compared.
Jushi Company Profile
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.
Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with MarketBeat.com's FREE daily email newsletter.